Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Lilly is studying retatrutide in several Phase 3 clinical trials to evaluate its potential efficacy and safety in obesity and overweight with at least one weight-related medical problem, type 2 diabetes, knee osteoarthritis, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes and metabolic dysfunction-associated steatotic liver disease
By the late 1970s admissions to hospital and the workload of gastric surgeons had begun to decline as a result of the introduction of H2 receptor agonists, a new class of drugs that block the action of histamine
Over time, though, patients began sharing stories of serious side effects that were not widely discussed
Alternative medications to retatrutide If your doctor recommends an alternative treatment to retatrutide, they may suggest other medications from different drug classes to manage or promote weight loss
US$ 27.98
US$ 26.82
US$ 21.90
US$ 23.28
